TrialPanorama/TrialPanorama-database huggingface dataset:
Study 30660511 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30660511 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 30661197 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30663562 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 30663562 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30664496 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study 30667281 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30670069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30670372 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 30670498 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30671005 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 30677460 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 30679147 — Predictive Biomarker (PRD): PSMB6 mRNA
Genes: PSMB6; LMPY; Y
Study 30679151 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 30679333 — Predictive Biomarker (PRD): ADCY10 mRNA
Genes: ADCY10; SAC
Study 30680179 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 30681551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30681643 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 30681793 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study 30681965 — Surrogate Endpoint (SUR): Blood pressure
Study 30683464 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 30684076 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30685808 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30686583 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 30686767 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 30688008 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30689735 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30689904 — Surrogate Endpoint (SUR): Serum triglycerides
Study 30689971 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 30691921 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 30692121 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 30692121 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 30692613 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 30693439 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30693439 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30695649 — Predictive Biomarker (PRD): NLRC4 mRNA
Genes: NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215
Study 30696435 — Surrogate Endpoint (SUR): Blood pressure
Study 30696435 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30696435 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30696487 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30696487 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 30696950 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 30696950 — Predictive Biomarker (PRD): TSC22D3 mRNA
Genes: TSC22D3; DSIPI; GILZ
Study 30696950 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30696950 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 30697903 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30698082 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 30698644 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30700274 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 30701920 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 30701920 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30701920 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 30701920 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30703787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30704966 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 30706490 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 30706490 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 30706646 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 30707510 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 30708264 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30709364 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 30710527 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study 30710527 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 30710573 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 30711772 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 30711772 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study 30711772 — Pharmacodynamic Biomarker (PDY): Hexamethylene bis-acetamide-inducible protein 1
Genes: HEXIM1; CLP1; EDG1; HIS1; MAQ1
Study 30713786 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30714026 — Surrogate Endpoint (SUR): Blood pressure
Study 30714987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30715229 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 30715588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30715588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30717802 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 30717802 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 30718102 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30718102 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 30718102 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 30718102 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 30718102 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 30718102 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 30718102 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30718102 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30718102 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30718541 — Safety Biomarker (SAF): PPOX
Genes: HCRT; OX
Study 30718945 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 30720689 — Predictive Biomarker (PRD): DOCK8 mRNA
Genes: DOCK8
Study 30721110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30721110 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30721917 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 30723079 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 30723079 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ADAM11 mRNA
Genes: ADAM11; MDC
Study 30723079 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 30723079 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 30723727 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 30723894 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30724422 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 30724423 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30724734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30725402 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study 30726108 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30726108 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study 30726175 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 30726175 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30726175 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30728140 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30729531 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30730031 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study 30730411 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 30730411 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 30730411 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 30730411 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 30730411 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 30730411 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 30730411 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 30731276 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30732640 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 30736150 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 30736818 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30736848 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 30736848 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study 30736848 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30739258 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30740662 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 30740673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30740673 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 30741694 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study 30742211 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 30742211 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 30742559 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 30742809 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30744116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30744116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30744680 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 30745123 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study 30745256 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 30745365 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30746344 — Predictive Biomarker (PRD): PON2 mRNA
Genes: PON2
Study 30746344 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30747243 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30753254 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 30753274 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30753274 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30753274 — Predictive Biomarker (PRD): Hormone receptor
Study 30753496 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30753611 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30755498 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 30755498 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study 30755907 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30756308 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study 30758276 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 30760105 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 30760246 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30760451 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30761066 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 30762508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30763338 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30763338 — Predictive Biomarker (PRD): Hormone receptor
Study 30764793 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study 30765035 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study 30765258 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30765258 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30766686 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 30766706 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 30767326 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 30767431 — Monitoring Biomarker (MOI): Cell-free DNA
Study 30767706 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 30767706 — Predictive Biomarker (PRD): SLC38A1 mRNA
Genes: SLC38A1; ATA1; NAT2; SAT1; SNAT1
Study 30767706 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study 30767706 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 30767706 — Safety Biomarker (SAF): UGT1A1
Genes: UGT1A
Study 30770348 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 30770362 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30770362 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30770394 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30770534 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 30770543 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 30770543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30771794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30771794 — Monitoring Biomarker (MOI): Procalcitonin
Study 30772387 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 30772905 — Surrogate Endpoint (SUR): Blood pressure
Study 30773021 — Predictive Biomarker (PRD): AHCY mRNA
Genes: AHCY; SAHH
Study 30773021 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 30773077 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 30774388 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 30774953 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30776019 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 30776920 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 30777875 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 30778520 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30778520 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30778520 — Predictive Biomarker (PRD): Hormone receptor
Study 30779990 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 30782611 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30782707 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 30782737 — Monitoring Biomarker (MOI): Procalcitonin
Study 30782744 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30782749 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 30785829 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30785829 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 30786000 — Surrogate Endpoint (SUR): Blood pressure
Study 30787176 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30787176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30788718 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30790403 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study 30790403 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 30792199 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 30792873 — Surrogate Endpoint (SUR): Blood pressure
Study 30795797 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 30795996 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 30796032 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30796032 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30796035 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 30796037 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30796119 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30796119 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30796119 — Predictive Biomarker (PRD): Hormone receptor
Study 30796821 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30797636 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30798615 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30800562 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 30801535 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 30801535 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 30801647 — Predictive Biomarker (PRD): BCO1 mRNA
Genes: BCO1; BCDO; BCDO1; BCMO1
Study 30801647 — Predictive Biomarker (PRD): SCARB1 mRNA
Genes: SCARB1; CD36L1; CLA1
Study 30801647 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study 30801647 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 30801647 — Predictive Biomarker (PRD): ELOVL2 mRNA
Genes: ELOVL2; ELG3; SSC2
Study 30801647 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 30802998 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study 30803705 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 30803990 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 30805405 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 30808583 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30808583 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30811063 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 30811085 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 30811285 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 30811475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30811475 — Monitoring Biomarker (MOI): Procalcitonin
Study 30811475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 30813845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30813845 — Surrogate Endpoint (SUR): Blood pressure
Study 30814321 — Surrogate Endpoint (SUR): Blood pressure
Study 30814321 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30814647 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30815467 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 30815984 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 30816108 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 30816108 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30817463 — Surrogate Endpoint (SUR): Blood pressure
Study 30819210 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30820530 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30821692 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 30821848 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 30821848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30821848 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 30821848 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30822272 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 30822515 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 30822515 — Surrogate Endpoint (SUR): Serum creatinine
Study 30823897 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD